Table 2
From: Description of the localized scleroderma subgroup of CARRAnet
| Â | Oral methotrexate | Subcutaneous methotrexate | Mycophenolate mofetil | Intravenous corticosteroids | Longterm daily corticosteroids |
|---|---|---|---|---|---|
Subjects (%) | 21/42 (50%) | 15/42 (36%) | 15/42 (36%) | 28-36 (78%) | 17/35 (49%) |
Current use | 12 | 4 | 4 | 5 | 5 |
Past use | 9 | 11 | 11 | 23 | 12 |